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Primary Ciliary Dyskinesia Caused by Homozygous
Mutation in DNAL1, Encoding Dynein Light Chain 1
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Micha Aviram,2 and Ruti Parvari1,3,*
In primary ciliary dyskinesia (PCD), genetic defects affecting motility of cilia and flagella cause chronic destructive airway disease,
randomization of left-right body asymmetry, and, frequently, male infertility. The most frequent defects involve outer and inner dynein
arms (ODAs and IDAs) that are large multiprotein complexes responsible for cilia-beat generation and regulation, respectively. Although
it has long been suspected that mutations in DNAL1 encoding the ODA light chain1 might cause PCD such mutations were not found.
We demonstrate here that a homozygous point mutation in this gene is associated with PCD with absent or markedly shortened ODA.
The mutation (NM_031427.3: c.449A>G; p.Asn150Ser) changes the Asn at position150, which is critical for the proper tight turn
between the b strand and the a helix of the leucine-rich repeat in the hydrophobic face that connects to the dynein heavy chain.
The mutation reduces the stability of the axonemal dynein light chain 1 and damages its interactions with dynein heavy chain and
with tubulin. This study adds another important component to understanding the types of mutations that cause PCD and provides
clinical information regarding a specific mutation in a gene not yet known to be associated with PCD.Cilia are ancient, evolutionarily conserved organelles that
project from the surfaces of most cells to perform diverse
biological roles, including whole-cell locomotion; move-
ment of fluid; chemo-, mechano-, and photosensation;
and paracrine signal transduction. These organelles can
be classified according to the arrangement of their micro-
tubule cytoskeleton core, called an axoneme.1 The
axoneme consists of nine outer-doublet microtubules,
which are connected by nexin links and surround a central
pair of microtubules (i.e., 9 þ 2 pattern). In some cilia, the
central pair of microtubules is absent (i.e., 9 þ 0 pattern).
The 9 þ 0 primary cilia are immotile, except in the embry-
onic node, where they are involved in left-right asymme-
try.2 The 9þ 2motile cilia, structurally identical to sperma-
tozoan flagella, are involved in the transport of
extracellular fluids, as in the respiratory tract, where they
propel mucus and therefore represent the first line of
airway defenses.1 Motile cilia are powered by outer dynein
arms (ODAs) and inner dynein arms (IDAs), multiprotein
ATPase complexes that are attached to the peripheral
doublets and are essential for ciliary motion.1 For most
motile cilia, additional accessory structures, for example
radial spokes and central pair projections, are involved in
regulating dynein-mediated motility.
Primary ciliary dyskinesia (PCD [MIM 242650]) refers
to a heterogeneous group of genetic disorders character-
ized by ultrastructural defects in the axonemal structure
of the 9 þ 2 motile cilia and sperm flagella.3 The incidence
is estimated at 1:15,000–30,000,4 and there is a higher
incidence in certain consanguineous and isolated popula-
tions.5,6 Clinical features reflect the distribution of
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The Amedistress, chronic respiratory infections, sinusitis, and bron-
chiectasis because of deficient function of motile cilia in
the upper and lower airways. Male and female subfertility
occur as a result of defective sperm flagella and oviduct
cilia, respectively. Occasionally, hydrocephalus occurs as
a result of deficient ependymal cilia.7,8 In most families,
there is an apparent randomization of left-right axis devel-
opment; this randomization is proposed to result from the
defective function of the embryonic node. This manifests
in about half of patients as situs inversus ormore severe lat-
erality defects, such as cardiovascular abnormalities. The
association of PCD and situs inversus is also referred to as
Kartagener’s syndrome (MIM 244400).9,10 There is a large
variation in the severity of the clinical phenotype. Clinical
features of PCD can also mimic those of other diseases,
such as cystic fibrosis, allergies or immunologic disorders.
Studying the ciliary-beat pattern and frequency by direct
microscopy on transnasal brushings and examining the
axonemal structure of respiratory cilia by transmission
electron microscopy allows diagnosis of PCD. Typical
ultrastructural defects in PCD consist of total or partial
absence of dynein arms, absence or dislocation of central
tubules, defects of the radial spoke, and peripheral micro-
tubule anomalies. However, in a subset of patients, no
ultrastructural defect are observed.11,12 Additionally, in
patients with PCD, nasal nitric oxide (nNO) levels are often
extremely low in comparison to controls. A nNO concen-
tration of <200 ppb could indicate PCD.13
PCD is usually recessively inherited, and mutations
that cause PCD have been identified in several genes and
chromosomal loci.9 Most of the genes encode axonemal
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Figure 1. PCD Bedouin Pedigrees, Fine Mapping of the Chromosome 14 Locus in Pedigree A, and Absence of the ODAs in Patient
Cilia
(A) The haplotype analysis based on microsatellite markers from 14q24.2-q31.3 revealed a founder haplotype (gray bar) for which the
patients are homozygous in the critical region harboringDNAL1. The numbers of the patients correspond to those presented in Table 1.
Patient IV-1 of family B was identified by analysis of the mutation. Filled symbols represent the homozygote for the mutation and
a double line indicates a consanguineous union. The two lines indicate the crossing events delimiting the homozygous interval shared
by the two patients. Markers rs17176306 and rs41471545 define the minimal homozygosity locus associated with the disease.
(B) Transmission electronmicrograph of nasal ciliary epithelium from patient IV-1 of family A in comparison to a control (sibling IV-3 of
family A). The arrows in the micrographs point to the ODA that is missing in the patient.axonemal ODAs, which are the multisubunit axonemal
ATPase complexes that generate the force for cilia motility
and govern beat frequency. Mutations in DNAH5 (MIM
603335) and DNAI1 (MIM 604366) are a relatively more
common cause of disease, underlying an estimated 28%
(DNAH5)14 and 2%–10% (DNAI1)15,16 of total cases. The
other genes are so far only associated with single or rare
PCD cases; therefore, the genetic basis of at least 60% of
PCD cases is not yet known. These genes include addi-
tional components of dynein arms: DNAI2, DNAH11,
and TXNDC3.17 Mutations in genes encoding cytoplasmic
proteins such as KTU and LRRC50 affect the assembly
of both IDA and ODA complexes in the cytoplasm by
a process that is still poorly understood.18–21 Mutations
in RSPH9 and RSPH4A, encoding two radial spoke head
proteins, have been recognized in Pakistanis and
Bedouins.22 These mutations cause primary ciliary dyski-
nesia with central-microtubular-pair abnormalities
involved in central-pair defects. Lastly, it was recently
reported that mutations in CCDC3923 and CCDC40,24
two proteins for coiled-coil domains, cause a PCD variant
that is characterized by misplacement of the central pair
of microtubules and defective assembly of IDAs and
dynein regulatory complexes. CCDC40 localizes to motile
cilia at the apical cytoplasm and is required for axonemal
recruitment of CCDC39;24 the latter underlies a substantial
fraction of PCD cases with axonemal disorganization and
abnormal ciliary beating.23600 The American Journal of Human Genetics 88, 599–607, May 13,We have identified two consanguineous Bedouin fami-
lies with three PCD patients (Figure 1A). The patients
had the classical presentation of PCD, the clinical data
and laboratory findings that established the PCD diagnosis
of the patients are presented in Table 1. Example transmis-
sion electron microscope images demonstrating the
absence of eight out of the nine ODAs and occasional
marked shortening of the ninth is shown in Figure 1B in
comparison to the healthy homozygous normal sibling
IV-3. The same ODA defect was observed in a total of
37 cilia documented from the two patients of family A.
Additional images of the 2 patients are presented in
Figure S1, available online.
The study was approved by the institutional review
board of the Soroka Medical Center, and informed consent
was obtained from all participants or their legal guardians.
Genomic DNA was isolated by standard methods directly
from blood samples. Assuming disease by homozygosity
of a mutation from a common ancestor, we excluded
linkage to the DNAH5 andDNAI1 by the finding of hetero-
zygosity of alleles at known polymorphic markers adjacent
to these genes.25 We further searched for homozygous
regions consistent with linkage by genotyping the patients
and both parents from pedigree A with the Affymetrix
(Santa Clara, CA) GeneChip Human Mapping 250K
Sty arrays. We determined the genotype calls by using Af-
fymetrix GeneChip Genotyping Analysis Software
(GTYPE) and dedicated software KinSNP developed in2011
Table 1. Clinical Data and Laboratory Findings of the PCD Patients
Family A Family B
Patient IV-1 Patient IV-2 Patient IV-1
Patient characteristics
Age/gender 17.5 years/male 14.5 years /female 6.6 years/male
Complete situs inversus yes yes yes
Neonatal period neonatal pneumonia tachypnea, oxygen
requirement for 12 days
tachypnea, oxygen
requirement for 18 days
Reactive airway disease yes yes yes
Chronic nasal discharge yes yes yes
Chronic serous otitis media yes yes yes
Bronchiectasis yes yes no
Surgery no yes: adenoidectomy at 5.5 years,
lymphangioma in right forearm
ventilation tubes
Cilia movementa weak movement weak movement no movement
Electron microscopy absence of ODAs absence of ODAs absence of ODAs
nNO 5 ppb 3 ppb not done
Pulmonary function tests
Forced vital capacity (FVC)b 105% 103% not done
Forced expiratory volume in 1 s (FEV1)c 61% 76% not done
FEV1/FVC 54% 70% not done
Forced midexpiratory flow rated 25% 40% not done
The following abbreviations are used: ODAs, outer dynein arms; nNO, nasal nitric oxide; and ppb, parts per billion.
a Ciliary movement was measured by direct light microscopy.
b The volume of air that can forcibly be blown out after full inspiration, measured in liters.
c The average values for FEV1 in healthy people depend mainly on sex and age, and values between 80% and 120% of the average value are considered normal.
d The rate of flow between 25% and 75% of the FVC. Its value is determined from the FVC curve, and it is reduced in early obstruction involving the smaller
airways.house to automatically perform autozygosity analysis of
the microarray results.26 A single large homozygous region
between rs17176306 and rs41471545 (>16 cM and
14.4 Mb) on chromosome 14 was found to be shared by
the two affected patients. To confirm linkage to this region,
we tested all family members with both known polymor-
phic microsatellite markers and with additional markers
developed for this purpose.27 Linkage was identified to
chromosomal locus 14q24.2-q31.3, chr14: 70,128,727–
84,524,979 (NCBI Build 36.1) (Figure 1A). We calculated
the multipoint Lod score by using the Pedtool server and
assuming recessive inheritance with 99% penetrance and
an incidence of 0.01 or 0.001 for the disease allele in the
population, was 2.49.
The linkage interval contains 84 genes; by using the cil-
iaproteome server, we found 22 of them. Among these,
we considered DNAL1 to be the strongest candidate for
PCDbecause it encodes the ortholog of theChlamydomonas
axonemal dynein light chain 1 (LC1), an ODA component
that contains themolecularmotors for ATP-dependent cilia
movement. Therefore, we analyzed it first. Total RNA was
extracted from lymphoblastoid cells of patient IV-1 with
the EZ-RNA Reagent (Biologic Industries, Israel). ReverseThe Ametranscriptase reactions were performed with the Super-
Script II Reverse Transcriptase Synthesis Kit (Invitrogen).
The whole cDNA coding region for DNAL1 was amplified
in overlapping segments by PCR. No splice variants were
detected. The PCR products were directly sequenced on
an ABI PRISM 3100 DNA Analyzer with the BigDye Termi-
nator v. 1.1 Cycle Sequencing Kit (Applied Biosystems,
CA, USA) according to the manufacturer’s protocol. The
primers that revealed the mutation were primer 50-CC
CTAGCAACCAGAGCAGTGA-30 (forward) and primer
50-AGGTTGGCATTACCAGTTTTG-30 (reverse).We identified
a homozygous nonsynonymous variation (NM_031427.3:
c.449A>G; NP_113615.2: p.Asn150Ser) (Figure 2A). Because
the patient in family B is from the same population,
although not known to be related to family A, we evaluated
him for the p.Asn150Ser mutation by sequencing of a PCR
product amplified from his genomic DNA (see below) and
found to be homozygous for the mutation. His parents,
who were similarly analyzed, are heterozygous for this
variant. The patient’s siblings are either heterozygous
(IV-2) or homozygous normal (IV-3). Testing for the varia-
tion in all members of both families and controls was per-
formed by restriction analysis because the variation createsrican Journal of Human Genetics 88, 599–607, May 13, 2011 601
Figure 2. Identification of the DNAL1 Mutation
(A) Sequence of the genomic DNA corresponding to the c.449A>G mutation resulting in p.Asn150Ser. Patients were homozygous for
the mutation; parents and siblings carrying the founder haplotype were heterozygous, and the healthy siblings without the founder
haplotype were normal.
(B) Restriction analysis for family A with BsmFI enzyme. The 148 bp band (marked with a red arrow) is apparent only in the mutated
allele. The wild-type (fragments were 370 bp and, uncut, 495 bp) versus mutation (fragments were 370 bp and, cut, 148 bp and
347 bp) alleles.
(C) Evolutionary conservation of the sixth LRR domain (conserved residues defining the LRR consensus are in bold). Position 150 of the
mutated Asn is shown on top.
(D) Structural prediction of the mutated LC1 protein (MUT) in comparison to a normal (WT) structure performed by the SWISS-MODEL
tool. The change in structure is marked with a red arrow.a BsmFI restriction site that does not exist in the wild-type
sequence. PCR amplification of genomic DNA, around
exon 7 of the gene, was performed with the use of the
primers 50- CCTCCCATCCTGTACTGTCTTC-30 (forward)
and 50- GCTTTTGGTCTAGGGAGAATCTT-30 (reverse).
BsmFI restriction analysis of the PCR amplicons generated
differential cleavage products of the wild-type (fragments
were 370 bp and, uncut, 495 bp) versus variation
(fragments were 370 bp and, cut, 148 bp and 347 bp) allele.
Fragments were separated by electrophoresis on 2%agarose
gel (Figure 2B). This variation segregates as expected in the
families. Themutationwas found in the heterozygous state
in only one individual and was not found in the homozy-
gous state in any individuals out of 124 healthy Bedouin
controls.
We sought evidence for the pathogenic relevance of this
variation by analyzing the conservation of the protein602 The American Journal of Human Genetics 88, 599–607, May 13,sequence. Sequence alignment of the human DNAL1
with other species orthologs demonstrated complete
conservation of the leucine-rich-repeat (LRR) consensus
domain. Asn at position150 in human DNAL1 is one of
the LRR consensus residues (Figure 2C); it aligns with
the Asn located between the b10 and a7 folds of the sixth
LRR domain of the corresponding Chlamydomonas (LC1)
ortholog.28 Human DNAL1 is highly conserved: align-
ment of its predicted 3D structure to the orthologous
Chlamydomonas LC1 show minor differences, a loop
instead of a7 helix and shortened C terminus.29 We
verified the effect of the change on the protein conforma-
tion by using the SWISS-MODEL tool and found that
the replacement of Asn by Ser at position 150 indeed
has a major effect on the structure of the protein, in
that it disturbs the folding of the sixth LRR domain
(Figure 2D).2011
Figure 3. Effect of the Mutation on the
Stability of the DNAL1 Protein
(Top panel) A representative immunoblot
analysis presenting DNAL1 protein at 0,
3, and 6 hr after addition of CMX. GAPDH
is shown as a loading control. (Bottom
panel) Quantification of the DNAL1-Myc
stability relative to GAPDH for three exper-
iments. The densitometric ratio of DNAL1-
Myc to GAPDH at the time of addition of
CMX was established as 100% and the
ratio of the DNAL1 to GAPDH at 3 and
6 hr is compared to time 0. The data is pre-
sented as mean5 standard deviation. The
difference between the normal and
mutated protein at the two time points
was evaluated by a two-tailed Student t
test, assuming unequal variance. **p ¼
0.006, ***p¼ 0.001. The following abbrevi-
ations are used: MUT, mutated DNAL1
protein; and WT, normal DNAL1 protein.Next, we studied the effect of the mutation on the
protein. We subcloned the mutated and normal protein
sequences into the pc3myc plasmid to produce the DNAL1
protein fused at its N terminal to a Myc tag. In brief, we
used RNA from lymphoblastoid cells of patient IV-1 in
family A and lymphoblastoid cells of a healthy control to
reverse transcribe (byusing SuperScript II Reverse Transcrip-
tase Synthesis kit [Invitrogen]) and amplify the whole
coding sequence of DNAL1 by PCR with the primers
EcoRI-F, 50-GAATTCATGGCGAAAGCAACAACAATCAA-30,
and XhoI-R, 50-CTCGAGGTTGTCTTCTTCCTCATCCCC-30,
by using the DreamTaq DNA Polymerase (Fermentas). The
PCRproductwas restrictedwith EcoRI andXho-I and subcl-
oned into these sites of the plasmid. We sequenced the
inserts with the flanking regions with the T7 and SP6
primers to ascertain insertion in frame with the Myc tag
and to verify that no PCR mutations were introduced
during the cloning process. HEK293T cells were transiently
transfected with the constructs by using TransIT-LT1
reagent (Mirus) and lysed with RIPA lysis buffer 48 hr after
transfection. The DNAL1-Myc protein levels were studied
by immunoblot with a Myc antibody (gift of Noah Isakov).
Although the transfection conditions were identical, there
was a marked reduction (7-fold) in the quantity of the
mutated protein in comparison to the normal amount, as
estimated with the GAPDH protein as a loading control
(not shown). We tested the possibility that the observed
low level of the mutant protein is caused by its instability.
Forty-eight hours after transfection of HEK293T with
the DNAL1-Myc plasmid, cycloheximide (CMX, Sigma-Al-The American Journal of Humandrich), an inhibitor of protein transla-
tional elongation in eukaryotes, was
added (to a final concentration of
10 mg/ml). The quantities of mutated
and control DNAL1-Myc proteins,
starting from approximately equal
quantities, were compared by immu-noblot analysis at 3 and 6 hr after the addition of CMX. A
representative experiment, demonstrating faster reduction
in the quantity of the mutant protein than in that of the
normal protein, is shown in Figure 3A. To quantify this
reduction, we performed three independent experiments.
The intensity of the immunoblot signals was measured
with the Image Lab software (Bio-Rad). The densitometric
ratio of DNAL1-Myc to GAPDH at the time of addition of
CMX was established as 100%, and the ratio of the
DNAL1-Myc to GAPDH at 3 and 6 hr was compared to
time 0. Indeed, the quantity of the mutated protein was
reducedby40%and94%at 3 and6hr, respectively,whereas
the normal protein was reduced only by 10% and 30%. The
difference between the normal and mutated protein at the
two time points was evaluated by a two-tailed Student’s t
test, under an assumption of unequal variance (p < 0.01
and p < 0.001 at 3 hr and 6 hr, respectively) (Figure 3B).
In humans, dynein is composed of two heavy chains
(~500 kD), two intermediate chains (70–125 kD), and
several light chains (15–30 kD).30 The heavy chains
form the globular heads and stems of the complex. In
Chlamydomonas two molecules of LC1 are tightly associ-
ated with AAA nucleotide-binding domains of the g heavy
chain.28,31 The interaction of the LC1 is mediated through
a central LRR section that folds as a cylindrical, right-
handed spiral formed from six b-b-a motifs. This central
cylinder is flanked by terminal helical subdomains. The
C-terminal helical domain juts out from the cylinder and
is proposed to interact with the dynein heavy chain. The
position of the mutated aspargine is just at the last LRRGenetics 88, 599–607, May 13, 2011 603
Figure 4. Interaction of the Mutated and Normal DNAL1 Protein with the Dynein Heavy Chain and with Tubulin
(A) Schematic representation of the interaction of DNAL1 with the dynein heavy chain (DNAH) and tubulin.31,32
(B) Immunoprecipitation of dynein heavy chain. (a) Immunoprecipitation of the dynein heavy chain with the mutated (MUT) and
normal (WT) DNAL1-Myc by Myc antibody probed with an anti-dynein heavy chain antibody. (b) The beads were incubated solely
with the lysate mixture and axoneme and probed with an anti-dynein heavy chain antibody, thus presenting the background dynein
heavy chain signal in the immunoprecipitation. (c) Input quantity of DNAL1-Myc for the reaction. (d) Input quantity of dynein heavy
chain extracted from rat tracheas. The percentage in brackets refers to the loading on the gel of the lysate mixture with axoneme relative
to the quantity used for the immunoprecipitation. The antibody used for the Immunoblot analysis is denoted at the right side.
(C) Immunopercipitation of a-tubulin. (a) IP of a-tubulin with the mutated (MUT) and normal (WT) DNAL1-Myc by Myc antibody
probed with an anti-a-tubulin antibody. (b) The beads were incubated solely with the lysate mixture and axoneme and probed with
an anti-a-tubulin antibody, thus presenting the background of a-tubulin signal in the immunoprecipitation. (c) Input quantity of
a-tubulin for the reaction. (d) Input quantity of DNAL1. The percentage in brackets refers to the loading on the gel of the lysate mixture
with axoneme relative to the quantity used for the immunoprecipitation. The antibody used for the Western analysis is denoted at
the right side.
The stability of the mutated DNAL1 after the incubation with the axonemal extracts and with the primary antibody at 4C was
comparable to the normal DNAL1 (not shown).consensus that stabilizes the turn between the b strand and
the a helix. In humans, the ortholog of the g heavy chain
is encoded by two genes, DNAH5 and DNAH8,30 and
a similar association of DNAL1 to DNAH5 was also demon-
strated29. It was also shown that Chlamydomonas LC1
interacts directly with tubulin and tethers the g heavy
motor unit to the A tubule of the outer-doublet microtu-
bules within the axoneme31,32 (schematically presented
in Figure 4A). To verify whether the change in the mutated
protein effects binding between DNAL1 to dynein heavy
chain and to tubulin, we tested their direct interaction
by immunoprecipitation.
To obtain sufficient amounts of dynein heavy chain
proteins and microtubules for immunoprecipitation, we
prepared axonemal extracts from rat tracheas. Tracheas
with larynx were removed from rats and placed in ice-cold
saline. After excision of the larynx and removal of excess
connective tissue and fat, the tracheas were transferred to
fresh ice-cold saline. High-salt axonemal extracts were
prepared as previously described.33 We produced mutant
and normal DNAL1-tagged proteins by transfecting
HEK293T cells with the respective DNAL1-Myc plasmids
and incubated cell extracts containing equal quantities of
the normal and mutated DNAL1-tagged proteins (72 mg
and 500 mg of the normal and mutated protein extracts,
respectively) for 24 hr at 4C with equal amounts of rat
axonemal extracts (230 mg for each extract).Myc antibodies
were used for immunoprecipitation of the tagged DNAL1,
and the quantity of dynein heavy chain and tubulin in
the immunoprecipitate was tested by dynein heavy chain
antibody (Abcam, catalog number ab6305) and a-tubulin604 The American Journal of Human Genetics 88, 599–607, May 13,antibody (B-5-1-2, Abcam, catalog number ab11304),
respectively. Both dynein heavy chain and tubulin were
readily coimmunoprecipitated with the normal DNAL1-
tagged protein, whereas themutated protein showed about
80% reduction in the immunoprecipitated quantities of
both the dynein heavy chain and a-tubulin (Figures 4B
and 4C). The stability of themutatedDNAL1 after the incu-
bation with the axonemal extracts and with the primary
antibody at 4C was comparable to that of the normal
DNAL1. From these results, it can be concluded that the
physical interaction between the mutated DNAL1 protein
and both dynein heavy chain and tubulin is damaged.
Most of the genetically characterized PCD variants
exhibitmutations in genes that encode dynein armcompo-
nents that are responsible for ciliary-beat generation.14–21
Using a total genome scan, we now provide evidence that
a DNAL1 point mutation, inherited in a recessive manner,
causes PCD in two Bedouin families. The patients had the
classical presentation of PCD, characterized by complete
situs inversus, early neonatal respiratory distress, and
chronic sino-pulmonary infection leading to severe
morbidity. PCD was confirmed by the laboratory results
of very low nNO; a significant decrease in cilia movement,
determined by light microscopy; and an absence of ODAs,
determined by transmission electron microscopy. The
identification of a mutation in DNAL1 demonstrates that
the Chlamydomonas LC1 human ortholog, like other
components of the ODA, is important for ciliary function
in the airways. The presence of situs inversus in the patients
indicates that DNAL1 is also necessary for the function of
the cilia that produce the nodal flow essential for the2011
determination of left-right asymmetry.10 The function of
the orthologs of Chlamydomonas LC1 was intensively
studied in model systems. RNAi silencing of expression of
the LC1 ortholog of Trypanosoma brucei, TbLC1, resulted
in the complete loss of the dominant tip-to-base beat that
is a hallmark of trypanosome flagellar motility and the
concomitant emergence of a sustained reverse beat that
derived cell movement in reverse. Ultrastructure analysis
revealed that the outer-arm dyneins are disrupted in
TbLC1 mutants. Therefore, LC1 was shown to be required
for stable dynein assembly and forward motility in
T. brucei.34 The cloning and study of the LC1 ortholog of
Phytophthora nicotianae (PnDLC1) demonstrated that
RNAi-mediated silencing of PnDLC1 expression yielded
transformants that released nonflagellate, nonmotile
zoospores from their sporangia.35 The ciliated epithelium
of the planarian Schmidteamediterraneawas used for dissect-
ing the role of ODAmotors in the coordination of the oscil-
lations of neighboring cilia and the formation ofmetachro-
nal synchrony of motile cilia.36 Metachronal synchrony is
important for effective clearance of mucus and transport of
other periciliary fluids over the surface of the epithelium. It
is thought to be achieved by coupling betweenneighboring
cilia by a system that provides mechanical feedback.
Manipulation of the S. mediterranea by an RNAi vector so
that there was an absence of the ODAs resulted in a signifi-
cant decline in beat frequency and an inability of cilia to
coordinate their oscillations and form metachronal waves.
Specifically, similar manipulation to eliminate LC1 yields a
similar phenotype even though, in contrast to other
models, in this case the outer arms still assemble in the
axoneme. The lack ofmetachronywas not due to a decrease
in ciliary-beat frequency or to temporal variability in the
beat cycle of impaired cilia. Therefore, it was suggested
that LC1 acts in a mechanosensory feedback mechanism
controlling ODA activity, and thus the ciliary beat, based
on external conformational cues. This enables the coordi-
nation of ciliary beating and ultimately the formation of
metachronal waves.36 These data are consistent with obser-
vations of a Chlamydomonas mutant (oda-2t), which lacks
the outer arm heavy chain motor domain and LC1 and
exhibits pronounced motility defects.37 Interestingly, in
Chlamydomonas reinhardtii, a series of mutations affecting
the amino acids that are crucial for the structure of the
LC1a9 helix, which protrudes into the HC AAAþ domains
and is important for the interaction between LC1 and
heavy chain, demonstrated a dominant-negative adverse
effect. The swimming velocity was reduced, and the flagella
beat constantly out of phase and stalled near the power/
recovery stroke switch point.32 These findings again
support the suggestion that LC1 regulates the activity
outer-arm dyneins through a conformational switch.
Although the DNAL1 mutation replacing Asn150 with Ser
causes instability of the mutated protein, it does not lead
to its complete absence. Similarly, it does not completely
abolish the binding to either dynein heavy chain or to
tubulin. Thus, it is still possible that the Asn150Ser muta-The Ametion leads to a partial loss of protein function and has
a semidominant mode of transmission of the disease
phenotype, that is, a typical PCD phenotype in homozy-
gous individuals, whereas heterozygous carriers could
have a much less severe phenotype. Although, we were
not able to obtain nasal epithelial cells fromaheterozygote,
and thus cannot exclude a defect in the structure or move-
ment of the cilia, there is no support for a dominant effect
on the basis of clinical data; None of the parents or the he-
trozygous siblings suffered from any of the symptoms that
affected the of PCD patients (e.g., reactive airway disease,
chronic nasal discharge, chronic serous otitis media, situs
inversus). Moreover, there were no reports of any infertility
problems, the families having numerous children.
To date, the structure of LC1 of C. reinhardtii and its
interactions with the g heavy chain have been
resolved.28,31,38 The human (DNAL1) and murine (Dnal1)
orthologs of the Chlamydomonas LC1 gene were identified
and in silico protein analysis showed complete conserva-
tion of the LC1/g heavy chain-binding motif in DNAL1
and actual binding of DNAL1 to DNAH5,29 one of the
two human orthologs of the Chlamydomonas g heavy
chain.30 LC1 binds to the g heavy chain motor domain
and becomes crosslinked to a relatively small region
between the P1 ATP hydrolytic site and the P2 or P3 nucle-
otide-binding site.31,38 LC1 is a member of the LRR
subclass defined by SDS22þ (which contains 22-residue
repeats).This LRR motif structure consists of a b strand
and a a helix interconnected via a tight turn. The turn is
stabilized by a hydrogen-bonding network set up by the
invariant Asn residue. The conserved hydrophobic and
Asn side chains within the LRR consensus (LxxLxLxxNxL)
pack to form the hydrophobic core. A single hydrophobic
patch formed by the six central LRRs is exposed on the
molecular surface of LC1 and is presumed to mediate inter-
action with the g heavy chain. The C-terminal helical
domain juts out from the cylinder, is adjacent to the
hydrophobic surface within the repeat region that inter-
acts with the dynein heavy chain, and is suggested to insert
itself into the dynein ATP hydrolytic site.38 Attachment of
LC1 to this region represents the only known example of
an accessory polypeptide directly associated with the cata-
lytic motor domain of the dynein heavy chain. The Asn at
position 150 in DNAL1 aligns with the critical Asn that is
in the last LRR consensus of LC1 and that stabilizes the
turn between the b strand and the a helix by the side chain
that forms hydrogen bonds in the loop structure.
Additionally, this Asn is immediately adjacent to the
C-terminal helical domain that inserts itself into the ATP
hydrolytic site. Thus, the prediction that the mutation of
this Asn to Ser will eliminate the fold agrees with the
finding of the drastic reduction in the binding of the
mutated DNAL1 to dynein relative to the normal protein
because the replacement of the Asn’s with Ser probably
changes the pattern of hydrogen bonds in the loop.
The structural domain mediating the binding between
LC1 of C. reinhardtii and tubulin is not yet defined. Therican Journal of Human Genetics 88, 599–607, May 13, 2011 605
missense mutations of amino acids crucial for the structure
of the LC1 a9 helix, which is important for the interaction
of LC1 and g heavy chain, do not affect the binding to
tubulin.32 The drastic reduction in binding that we
observed with the p.Asn150Ser mutation might indicate
the importance of this residue, and possibly the whole
last LRR domain, to the interaction of DNAL1 with
tubulin. It is possible that the loss of tethering of the
dynein heavy chain to tubulin contributes to the recessive
mode of inheritance of the PCD in our families, in contrast
to the dominant negative effect observed for the missense
mutations of LC1 of C. reinhardtii.32
Our study also demonstrates the importance of the Asn at
position 150 for protein stability, in agreement with the
proposals of the importance of the proper folding of the
LRR domain for protein stability.39 Similarly, mutations
that replace the critical Asn in LRR with Ser were demon-
strated to cause several genetic diseases,40 such as congen-
ital stationary night blindness type 1 (CSNB1)/X-linked
congenital stationary night blindness (XLCSNB), which is
caused by p.Asn312Ser in nyctalopin. Another example
was observed in the ninth LRR domain of keratocan,
causing autosomal recessive cornea plana (CNA2) in which
the forward convex structure is flattened, leading to
a decrease in refraction. PCD was also demonstrated to be
caused by a mutation (p.Leu175Arg) disrupting a SDS22-
like subfamily LRR structure of LRRC50.18 This LRR might
participate in the structural link between the inner- and
outer-row dyneins during their preassembly.18,19
In summary, although the importance of the human
(DNAL1) ortholog of the Chlamydomonas LC1 gene was
already appreciated, and mutations in this gene had been
searched for in 86 PCD patients,29 we present evidence
that a mutation of a critical amino acid in DNAL1 causes
PCD. This mutation could help to elucidate the interaction
between the DNAL1 to dynein heavy chain and to tubulin.
Our finding adds DNAL1 as a gene mutated in PCD
patients and an important component of our under-
standing of the types of mutations that cause PCD.
Supplemental Data
Supplemental Data include one figure and can be found with this
article online at http://www.cell.com/AJHG/.
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